永安药业：拟吸收合并全资子公司凌安科技

Core Viewpoint - The company plans to absorb its wholly-owned subsidiary, Hubei Ling'an Technology Co., Ltd., which will be dissolved post-merger, with all assets, debts, and obligations transferred to the company [1] Financial Data Summary - As of December 31, 2024, Hubei Ling'an Technology reported total assets of 180 million yuan, total liabilities of 83.71 million yuan, and net assets of 96.22 million yuan [1] - For the period from January to September 2025, the subsidiary generated operating revenue of 70.47 million yuan, but reported a net loss of 11.15 million yuan [1]